awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38720855-87DB9EA4-0FFA-4115-995F-7B8FDF6B02DC
Q38720855-87DB9EA4-0FFA-4115-995F-7B8FDF6B02DC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38720855-87DB9EA4-0FFA-4115-995F-7B8FDF6B02DC
177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer.
P2860
Q38720855-87DB9EA4-0FFA-4115-995F-7B8FDF6B02DC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38720855-87DB9EA4-0FFA-4115-995F-7B8FDF6B02DC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7e8a4c4ed71802cc8321dd71cf05b0825c5f4da6
P2860
Radioligand therapy with 177Lu-PSMA-617 of metastatic prostate cancer has already been arrived in clinical use.